China
Africa
Explore chapters and articles related to this topic
A Comparative Review of the Role of Deep Learning in Medical Image Processing
Published in R. Sujatha, S. L. Aarthy, R. Vettriselvan, Integrating Deep Learning Algorithms to Overcome Challenges in Big Data Analytics, 2021
Erapaneni Gayatri, S. L. Aarthy
Fatty Liver Disease is brought about by the fat development in the liver. It occurs regularly in individuals who are corpulent and overweight. It is divided into two types: one is alcoholic fatty liver sickness and the other is non-alcoholic fatty liver disease (NAFLD). Generally, fat develops in the liver since liquor in NAFLD fat creates in individuals who do not drink a lot of liquor. Cao et al. (2020) collected information from 240 patients and split them into classes called typical, mild, tweak, and extreme NAFLD. They utilized a 2D ultrasound imaging dataset for the utilization of deep learning in quantitative examination histogram. The area under curve values give the best performance results for image processing methods. Another study (Reddy et al., 2018), for recognizing the fatty liver illness from the ultrasound images, built up one Computer-Aided Design model with deep learning, fine tuning, and transfer learning models for the classification of fatty liver sickness. Later on, another investigation (Byra et al., 2018), for calculating the measure of fat in the liver, proposed a Neural Network-based technique for NAFLD from ultrasound images. They utilized the Inception-ResNet-V2 profound convolutional neural organization to remove the undeniable level highlights from the liver. This technique may be very valuable for sonographers.
Big Data in Medical Image Processing
Published in R. Suganya, S. Rajaram, A. Sheik Abdullah, Big Data in Medical Image Processing, 2018
R. Suganya, S. Rajaram, A. Sheik Abdullah
Fatty liver, also known as fatty liver disease (FLD) is a reversible condition where large vacuoles of triglyceride fat accumulate in liver cells via the process of steatosis (i.e., abnormal retention of lipids within a cell). Despite having multiple causes, fatty liver can be considered a single disease that occurs worldwide in those with excessive alcohol intake and those who are obese (with or without effects of insulin resistance). The condition is also associated with other diseases that influence fat metabolism. Morphologically it is difficult to distinguish alcoholic FLD from non-alcoholic FLD and both show micro-vesicular and macrovesicular fatty changes at different stages.
Two mixed-ligand Cu(II) complexes: crystal structures and treatment activity on nonalcoholic fatty liver disease (NAFLD)
Published in Inorganic and Nano-Metal Chemistry, 2021
Jin-Jing Hong, Kai-Lun Hu, Jin-Chao Mao, Miao-Yao Lin
Nonalcoholic fatty liver disease (NAFLD) refers to a clinicopathological syndrome characterized by liver cell steatosis and lipid deposition in the liver cells. NAFLD is usually induced by multiple factors in addition to alcohol and other causes that clearly damage the liver [1]. As the NAFLD progresses, it can progress from simple fatty liver to nonalcoholic steatohepatitis (NASH), or even cirrhosis. The prevalence of NAFLD in the world is about 20%, and the prevalence of NAFLD in adults in China is about 15%, and the incidence is increasing in the recent years [2]. At present, the pathogenesis of NAFLD is not fully understood. Recent researches on the pathogenesis of NAFLD are mainly described in terms of lipid breakdown and storage disorders, insulin resistance, lipid peroxidation, inflammatory response and inflammatory cytokines stimulation, as well as endoplasmic reticulum emergency [3].
A Novel Method for Predicting Time of Alcohol Use Based on Personality Traits and Demographic Information
Published in IETE Journal of Research, 2022
Divya Kumari, Aleena Swetapadma
Alcohol abuse is one of the major global problems. Identifying alcohol abuse among individuals and predicting the time of use of alcohol can be very useful as the preventive measures can be taken accordingly. Alcohol consumption has many harmful effects such as heart diseases, diabetes mellitus, hypertension and heart stroke. It may lead to myocardial infarction, heart failure and atrial fibrillation [1]. Acute alcohol consumption results in motor vehicle crashes, which are one of the causes of death in the United States [2]. The effects of alcohol on connectivity from reward-related regions to visual and sensory cortical areas are explored in [3]. It discussed the relationship between alcohol use, religiosity and self-control in adolescent girls [4]. [5] explains that a limited intake of alcohol may decrease cardiovascular problems. In this case, determination of time of use of alcohol plays a vital role. In [6], it is already established that tobacco users are prone to become alcohol addicts. In [7], it is found that the individuals who use electronic cigarettes are most likely to have alcohol use disorder (AUD) and harmful patterns of alcohol use. Individuals with low socioeconomic status are at greater risk of drug consumption harm than those of higher socioeconomic status [8]. In [9], it has been suggested that alcohol-related liver disease, obesity and metabolic syndrome are closely related. Excessive intake of alcohol leads to chronic liver disease. Thus, guidelines for safe alcohol consumption should be used to prevent fatty liver disease. Moderate consumption of alcohol has minimal impact on reverse cholesterol transport (RCT) which helps in the removal of excess cholesterol from the body. But binge alcohol consumption increases the risk of cardiovascular diseases and impairs RCT [10].
Histological and immunohistochemical study of the effect of liraglutide in experimental model of non-alcoholic fatty liver disease
Published in Egyptian Journal of Basic and Applied Sciences, 2023
Mai Salah Nour, Zeinab Abd El-Hay Sakara, Nawal Awad Hasanin, Shereen Mohamed Hamed
More than 25% of the world’s population suffers from nonalcoholic fatty liver disease (NAFLD). The NAFLD patients may present with a variety of conditions, such as simple steatosis, nonalcoholic steatohepatitis, fibrosis and liver cirrhosis, which may result in hepatocellular cancer and hepatic failure [22].